Censys Launches Threat Hunting Solution to Proactively Track and Defend Against Targeted Adversaries
This solution helps security teams hunt faster, accelerate investigations and eliminate threats before they attack ANN ARBOR, Mich., April 28, 2025 /PRNewswire/ -- Today, Censys, known for its best-in-class Internet visibility, is launching a new...
Celltrion to present six abstracts in inflammatory bowel disease (IBD) at 2025 Digestive Disease Week® (DDW)
Six abstracts accepted for presentation includes post hoc analyses and real-world evidence for ZYMFENTRA ® (infliximab-dyyb) Findings reinforce clinical decision-making in long-term management of moderate-to-severe Crohn's disease and ulcerative...
Small Lab Co., Ltd., obtains FDA OTC approval. Leading the K-Beauty wave
SEOUL, South Korea, April 28, 2025 /PRNewswire/ -- SmallLab Inc, a microneedle platform company, has received final approval from the U.S. Food and Drug Administration (FDA) for its over-the-counter (OTC) drug manufacturing facility. Image povided...
Sky Labs' CART BP pro at the Heart of New Research on Sleep Apnea and Nocturnal Hypertension
SEOUL, South Korea, April 28, 2025 /PRNewswire/ -- Sky Labs, a health-tech startup based in South Korea and the developer of CART BP pro—a ring-type, cuffless device for 24-hour blood pressure monitoring—announced that a research presentation by...
TDH Holdings, Inc. Reports Full Year 2024 Audited Financial Results
BEIJING, April 28, 2025 /PRNewswire/ -- TDH Holdings, Inc. (NASDAQ: PETZ) ("TDH" or the "Company"), a PRC-based company that is an operator and manager of commercial real estate properties, announced today its financial results for the fiscal year...
Kangpu Biopharmaceuticals Received CDE Approval for Phase IIb Clinical Trial of KPG-818 in Moderate to Severe Cutaneous Manifestations of SLE
HEFEI, China, April 28, 2025 /PRNewswire/ -- Kangpu Biopharmaceuticals, Ltd. announced today that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has approved Phase IIb clinical trial of KPG-818...
WOORI FINANCIAL GROUP INC. FILES ITS ANNUAL REPORT ON FORM 20-F
SEOUL, South Korea, April 28, 2025 /PRNewswire/ -- On April 28, 2025, Woori Financial Group Inc. (NYSE:WF) (KRX:316140) filed its Annual Report on Form 20-F for the year ended December 31, 2024 with the U.S. Securities and Exchange Commission. The...
Jianpu Technology Inc. Files 2024 Annual Report on Form 20-F
BEIJING, April 28, 2025 /PRNewswire/ -- Jianpu Technology Inc. ("Jianpu" or the "Company") (OTCQB: AIJTY), a leading open financial technology platform in China, today announced it filed its annual report on Form 20-F for the fiscal year ended...